Keytruda
-
{
- All
- News
-
Which Cancers Does Keytruda Work On? Apollo Oncologists Explain Effectiveness
The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
Which Cancers Does Keytruda Work On? Apollo Oncologists Explain Effectiveness
The Drug Controller General of India (DCGI) has approved Keytruda for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
High Cost, Limited Access: How Counterfeit Keytruda Market Puts Cancer Patients At Risk
Keytruda, developed by Merck & Co., belongs to a class of drugs known as immune checkpoint inhibitors, which help the immune system identify and attack cancer cells.
-
Oncologists Explain Why They Prescribe Keytruda To Cancer Patients, When And How It Works
Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
-
What Is Keytruda And Why Is Everyone Talking About It In India's Cancer Fight?
In India, Keytruda is approved by the Drug Controller General of India (DCGI) for multiple cancer types. As of recent approvals, it covers 14 indications across eight tumour types.
